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Abstract
Introduction: The aim of this study was to evaluate serum levels and urinary excretion of neutrophil-gelatinase associated lipocalin 
(respectively sNGAL and uNGAL) and urinary excretion of Cathepsin L (uCathL) in children with type 1 diabetes mellitus (DM1) who 
presented normoalbuminuria and the estimated glomerular filtration rate (eGFR) above 90 mL/min/1.73 m2. 
Material and methods: The study group consisted of 63 children with a diabetes duration of 5.16 ± 3.39 years. The degree of albuminuria 
was based on urine albumin-to-creatinine ratio (ACR), while eGFR was based on serum cystatin C. Glomerular hyperfiltration (GH) was 
defined as an eGFR value above 135 mL/min/1.73 m2. 
Results: Children with DM1 showed significantly higher concentrations of uNGAL, and lower sNGAL and uCathL. Significant changes 
of uNGAL and uCathL levels were even found in children without GH and with optimal glycaemic control (HbA1c  <  7.5%). Positive 
correlations between uNGAL, ACR and eGFR were shown, as well as between uCathL and eGFR. 
Conclusions: Significant changes in the concentration of markers of early kidney injury: sNGAL, uNGAL, and uCathL, can occur in children 
with DM1 and normoalbuminuria. The changes of uNGAL and uCathL can be even found in children without GH and with optimal gly-
caemic control. The earliest signs of diabetic kidney dysfunction seem to result from tubular damage. (Endokrynol Pol 2014; 65 (6): 479–484)
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Streszczenie
Wstęp: Celem pracy była ocena stężenia w surowicy i w moczu markerów wczesnego uszkodzenia nerek, to jest lipokainy związanej z 
żelatynazą neutrofilii (odpowiednio sNGAL i uNGAL) oraz wydalania z moczem katepsyny L (uCathL) u dzieci z cukrzycą typu 1 (DM1) 
wykazujących normoalbuminurię i filtrację kłębuszkową (eGFR) powyżej 90 ml/min/1,73 m2.
Materiał i metody: Grupę badaną stanowiło 63 dzieci ze średnim czasem trwania DM1 wynoszącym 5,16 ± 3,39 roku. Albuminurię 
oceniano za pomocą wskaźnika albuminowo-kreatyninowego (ACR). eGFR obliczano na podstawie stężenia cystatyny C. Hiperfiltrację 
kłębuszkową (GH) definiowano jako wartość eGFR  >  135 ml/min/1.73 m2.
Wyniki: U dzieci z DM1 w porównaniu do grupy kontrolnej wykazano znamiennie wyższe stężenia uNGAL, niższe sNGAL i uCathL. 
Istotne zmiany stężeń uNGAL i uCathL stwierdzono już u dzieci bez GH i z optymalną kontrolą glikemii (HbA1c  <  7,5%). Stwierdzono 
pozytywną zależność pomiędzy uNGAL, ACR i eGFR oraz pomiędzy uCathL i eGFR.
Wnioski: Istotne zmiany w stężeniu markerów wczesnego uszkodzenia nerek to jest sNGAL, uNGAL i uCathL mogą wystąpić u dzieci 
z DM1 i normoalbuminurią. Zmiany uNGAL i uCathL mogą wystąpić nawet u chorych bez GH oraz wykazujących optymalną kon-
trolę glikemii. Pierwsze objawy zaburzenia czynności nerek w przebiegu DM1 wydają się wynikać z uszkodzenia cewek nerkowych. 
(Endokrynol Pol 2014; 65 (6): 479–484)
Słowa kluczowe: dzieci z cukrzycą; biomarkery; hiperfiltracja; mikroalbuminuria
Introduction
A global increase in diabetes mellitus incidence of about 
3% per year over the last decade has been recorded, 
with the most rapid increase in the youngest paediatric 
population in Europe [1]. One of the most dangerous 
complications of the disease is diabetic kidney dis-
ease (DKD). Patients with type 1 diabetes (DM1) face 
a 20–50% probability of developing end stage renal 
disease (ESRD) [2]. There are several risk factors which 
are responsible for the development of DKD, including 
hyperglycaemia, reflected by high haemoglobin A1c 
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albuminuria was performed three times in the first 
early morning urine sample over three months. The 
urine sample, collected on the same morning as the 
blood sample, was chosen for laboratory and statistical 
analysis. Long-term glycaemic control was based on 
haemoglobin A1c (HbA1c) levels [19]. Glycaemic controls 
were classified as follows: ideal — below 6.5% HbA1c; 
optimal — below 7.5%; suboptimal — between 7.5 and 
9.0%; and poor — above 9.0% HbA1c. Glomerular hy-
perfiltration (GH) was defined as the sum of the mean 
and two standard deviations calculated for eGFR in the 
control group [20]. In this study, GH was defined as an 
eGFR value above 135 mL/min/1.73 m2. There were no 
children with hypertension in the study group. None 
was overweight or obese. 
The control group consisted of 22 healthy, age- and 
gender-matched children. The study protocol was 
approved by the local Ethics Committee; every par-
ticipant and their parents/legal guardians gave fully 
informed consent to take part in the study. The study 
was conducted according to the principles listed in the 
Declaration of Helsinki. 
NGAL and uCathL ELISA assay
Blood and urine samples were taken at the same time 
in the morning before food intake. All urine and blood 
specimens were used within three months after collec-
tion. NGAL was measured in serum and urine, using 
CircuLex Human NGAL/Lipocalin-2 ELISA Kit, while 
uCathL was measured in urine using Bender MedSys-
tems ELISA Kit. Inter- and intra-assay coefficients of 
variations were 5–10%. To avoid differences in spot 
urine, all studied urinary markers were corrected for 
urinary creatinine. Common biochemical parameters 
were measured according to standard methods in 
a standard clinical laboratory.
The results of the biomarkers were normally distrib-
uted and parametric testing was used to compare all 
concentrations between groups (Student’s t-test). Values 
that followed a normal distribution are expressed as 
mean and standard deviation. The relationship between 
two variables was assessed by Person correlation coef-
ficient. The level of statistical significance was < 0.05. 
Results
The demographic and clinical data of the study group 
and controls are provided in Table I. 
NGAL and uCathL studies
Children with DM1 showed significantly elevated uN-
GAL values compared to controls. sNGAL and uCathL 
were significantly lower in the study group compared 
to controls (Table II). 
(HbA1c) [3], but the predictors of DKD are only partly 
known.
Since the 1980s, microalbuminuria (MA) has been 
established as an early marker of progressive glomeru-
lar kidney disease in diabetes, starting at paediatric age 
[4–7]. However, some patients develop DKD without 
preceding MA and less than one third of patients with 
MA have typical glomerulopathy [8]. Some studies 
in human type 1 diabetes highlight the occurrence 
of glomerular hyperfiltration (GH) as a risk factor for 
nephropathy, which may precede an increase in albu-
minuria [9]. However, this remains controversial and 
the mechanisms responsible for GH have not been 
fully evaluated.
In recent years, neutrophil gelatinase-associated 
lipocalin (NGAL) has emerged in clinical and experi-
mental nephrology as one of the most hopeful tubular 
biomarkers in the diagnostic field of acute and chronic 
renal diseases including glomerular diseases and DKD 
[10–15]. In patients with diabetic nephropathy, uNGAL 
predicts ESRD and even death [16]. However, the source 
and the time course of uNGAL concentration are not 
fully known.
Cathepsin L belongs to a subclass of cysteine 
proteases termed lysosomal cathepsins, which are 
primarily responsible for tissue turnover and protein 
breakdown in the kidney [17]. An analysis of kidney 
biopsy revealed increased activity of Cathepsin L in the 
glomeruli of patients with diabetic nephropathy. Induc-
tion of cytoplasmic Cathepsin L in glomeruli leads to the 
cleavage of dynamin, and the resulting reorganisation 
of the podocyte actin cytoskeleton and proteinuria [17]. 
With the present study, we aimed to evaluate serum 
levels and urinary excretion of NGAL and urinary 
excretion of uCathL in a cohort of children with type 
1 diabetes mellitus who presented normoalbuminuria 
and estimated glomerular filtration rate (eGFR) above 
90 mL/min/1.73 m2. 
Material and methods 
Patient and control groups
The study group consisted of 63 children with 
DM1 (28 males and 35 females) with a mean age of 
13.46 ± 2.95 years. The average treatment time was 
5.16 ± 3.39 years. Children with infections, inflam-
matory states, proteinuria, pyuria or haematuria 
or any renal impairment were excluded to avoid 
potential confounding factors. All patients had an 
estimated glomerular filtration rate (eGFR) above 
90 mL/min/1.73 m2 according to the Filler formula 
based on serum cystatin C concentration, and urinary 
albumin excretion below 30 mg/g defined by the urine 
albumin-to-creatinine ratio (ACR) [18]. Screening for 
481
Endokrynologia Polska 2014; 65 (6)
PR
A
C
E 
O
RY
G
IN
A
LN
E
Comparison of the study subgroups to controls 
depending on eGFR level (Table III)
GH was confirmed in 30% of children. In this subgroup, 
we found a significantly lower value of sNGAL and 
higher uNGAL as well as ACR and poor glycaemic con-
trol. uCathL level in these children did not differ com-
pared to controls. Patients without GH differed from 
controls only in terms of uNGAL, uCathL and HbA1c. 
Comparison of the study subgroups to controls 
depending on HbA1c level (Table IV)
uNGAL levels were significantly higher in children 
with optimal, suboptimal and poor glycaemic control, 
while sNGAL values were lower even in children with 
ideal glycaemic control. uCathL concentrations were 
significantly lower only in the subgroup with ideal and 
suboptimal glycaemic control. GFR and ACR values 
were significantly higher compared to controls only in 
children with poor glycaemic control. 
Correlations
A positive correlation between uNGAL and ACR, eGFR 
and HbA1c was found, as well as between uCathL and 
eGFR. The values of sNGAL showed a positive correla-
tion only with WBC. The results are provided in Table V. 
HbA1c levels revealed a positive correlation with eGFR 
(r = 0.399; p = 0.014) and ACR (r = 0.268; p = 0.034). 
However, eGFR and ACR values were not significantly 
correlated. 
In the subgroup with GH, a significant inverse 
correlation between uNGAL and sNGAL (r = –0.580; 
p = 0.048) was found. There was no correlation found 
between sNGAL and WBC in these patients.
In the subgroup without GH, a positive cor-
relation between uNGAL and sNGAL (r = 0.402; 
p = 0.046), as well as between sNGAL and WBC (r = 0.712; 
p < 0.001), was found.
Discussion
It is well known that pathological albuminuria and 
proteinuria are the consequences of diabetes-induced 
glomerular damage. However, renal tubulointer-
stitium seems to play a major role in the genesis of 
DKD. Changes in the proximal tubule are important 
for the development of progressive diabetic kidney 
disease [21]. 
The results of the present study show elevated 
uNGAL and reduced sNGAL and uCathL in children 
with DM1 compared to controls. Increased uNGAL is in 
perfect accordance with the results reported elsewhere, 
showing similar tendencies for NGAL in patients with 
Table I. Demographic and clinical data of the study group and controls
Tabela I. Dane demograficzne i kliniczne grupy badanej i kontrolnej
Study group 
Mean ± SD
Controls 
Mean ± SD
P
Age (years) 13.46 ± 2.95 12.12 ± 4.74 p = 0.451
Gender (female/male) 35/28 14/8 NA
RBMI (%) 104.72 ± 13.41 101.81 ± 16.57 p = 0.341
Treatment time (years) 5.16 ± 3.39 NA NA
ACR [mg/g] 10.8 ± 9.84 9.13 ± 5.25 p = 0.857
eGFR [mL/min/1.73 m2] 116.89 ± 23.18 110.11 ± 12.41 p = 0.427
HbA1c (%) 8.56 ± 2.10 5.43 ± 0.2 p  <  0.001
NA — not applicable; SD — standard deviation; RBMI — relative body mass index
Table II. Differences in sNGAL, uNGAL and uCathL concentrations between study group and the controls
Tabela II. Porównanie stężeń sNGAL, uNGAL i uCathL grupy badanej do grupy kontrolne
Study group 
Mean ± SD
Controls 
Mean ± SD
p
sNGAL [ng/mL] 109.96 ± 50.06 151.34 ± 53.95 p < 0.001
uNGAL [ng/mg] 43.02 ± 45.68 6.85 ± 6.05 p < 0.001
uCathL [ng/mg] 4.32 ± 1.61 5.18 ± 0.95 p = 0.007
SD — standard deviation
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DM1 [11, 22, 23]. Considerable enzymuria, in particular 
uNGAL, in early stages of diabetes suggests tubular 
dysfunction before signs of glomerular damage be-
come evident. In the studied patients, a significant rise 
of uNGAL occurred even in those without GH. Thus, 
the increase of uNGAL may reflect subclinical tubular 
impairment, representing an earlier measurable index 
of renal distress. Urinary NGAL was related to the 
degree of ACR, even within a low range. This may 
indicate glomerular involvement in the pathogenesis 
of DKD. However, some authors claim that in diabetes, 
albumin excretion is caused by tubular dysfunction and 
Table III. Comparison of patients without and with glomerular hyperfiltration to the controls
Tabela III. Porównanie wybranych parametrów u pacjentów z i bez hiperfiltracji do grupy kontrolnej
Parameters
Study group Controls
eGFR level (mL/min/1.73 m2); mean ± SD
Mean ± SD90  >  eGFR ≤ 135; n = 44  >  135; n = 19; GH
sNGAL [ng/mL] 129.57 ± 56.66 111.33 ± 48.86
151.34 ± 53.95p NS p = 0.031
uNGAL [ng/mg] 25.23 ± 37.14 56.41 ± 44.76
5.56 ± 4.37p p = 0.018 p  <  0.001
uCathL [ng/mg]  
3.66 ± 0.37
5.16 ± 2.44
5.18 ± 0.95
p p < 0.001 NS
ACR [mg/g] 8.63 ± 5.42 14.27 ± 6.41
9.13 ± 5.25p NS p = 0.021
eGFR [mL/min/1.73 m2] 103.24 ± 13.03 145.35 ± 9.06
110.11 ± 12.41p NS p < 0.001
HbA1c (%) 7.87 ± 1.48 10.51 ± 2.76
5.44 ± 0.21p p < 0.001 p < 0.001
GH — glomerular hyperfiltration; NS — not significant; p — confidence level; SD — standard deviation
Table IV. Comparison of the study subgroups to the controls depending on HbA1c level
Tabela IV. Porównanie grupy badanej do grupy kontrolnej w zależności od wartości HbA1c
HbA1c level (%); mean ± SD
Controls
Mean ± SD
≤ 6.5; n = 9
6.02 ± 0.29%
ideal glycaemic 
control
6,5 > HbA1c ≤ 8; n 
= 21
7.21 ± 0.40%
optimal glycaemic 
control
8 > HbA1c ≤ 10;n = 20
8.98 ± 0.55%
suboptimal glycaemic 
control
 > 10; n = 13
11.86 ± 1.41%
poor glycaemic 
control
sNGAL [ng/mL] 106.62 ± 34.96 114.32 ± 59.11 120.43 ± 52.86 89.15 ± 34.56
151.34 ± 53.95p p = 0.026 p = 0.011 p = 0.044 p = 0.001
uNGAL [ng/mg] 24.95 ± 38.35 40.34 ± 37.95 41.38 ± 45.88 62.41 ± 58.29
6.85 ± 6.05p NS p = 0.013 p = 0.003 p < 0.001
uCathL [ng/mg]   3.59 ± 0.72 4.53 ± 1.23 3.72 ± 0.30 5.41 ± 3.16
5.18 ± 0.95p p = 0.012 NS p = 0.005 NS
ACR [mg/g] 8.44 ± 5.69 9.09 ± 5.46 6.96 ± 3.66 16.83 ± 6.60
9.13 ± 5.26p NS NS NS p = 0.004
eGFR [mL/min/1.73 m2] 109.09 ± 10.22 109.861 ± 23.79 110.53 ± 21.82 138.56 ± 20.26
110.75 ± 12.41p NS NS NS p = 0.005
NS — not significant; p — confidence level; SD — standard deviation
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reduced lysosomal albumin degradation in proximal 
tubule cells [24].
Similar tendencies for NGAL in patients without 
the appearance of pathological albuminuria have been 
reported by other researchers [11, 22, 23].
In the present study, increased urinary loss of 
NGAL was accompanied by decreased serum NGAL 
concentration. This was previously described in an 
animal model of DM1 [22]. In human studies in type 2 
DM (DM2), an elevated level of sNGAL was revealed; 
however, the studied patients showed normal or re-
duced eGFR [23]. Elevation of sNGAL was probably the 
consequence of glomerular damage and reduced eGFR. 
It might be also attributable to the increased lipocalin 
activity in patients with insulin resistance associated 
with obesity, which is characteristic for DM2 [25]. 
In our study, children were not obese and 30% of 
them showed GH. sNGAL values in children with GH 
were found to be significantly lower compared to con-
trols. This observation may be indicative of the potential 
influence of hyperfiltration on sNGAL concentration; 
however, there is no similar data in the literature and 
some further research would have to be conducted on 
a larger study group. 
There are only a few reports about cathepsins in 
DKD. Most of them refer to urinary Cathepsin B and 
show an increased loss in rats and in patients with DM2 
[26, 27]. In rats, the activity of Cathepsins L and B was 
shown to be significantly decreased, which may be as-
sociated with renal hypertrophy in early diabetes [28]. 
Decreased activity of uCathL in diabetes may result 
from the inhibition by transforming growth factor beta 
(TGF-β) [24] and may lead to albumin loss resulting 
from the dysfunction of the degradation pathway and 
altered lysosomal processing in renal tubules. However, 
the potential importance of uCathL in DKD needs 
further investigation.
The results of our study confirm that the mecha-
nism of early kidney damage in diabetes is not com-
pletely understood. They provide no clear answer to 
the question as to which part of the kidney is damaged 
first: tubuli or glomeruli. The results of the present 
study have revealed that significantly elevated uN-
GAL, known to be a biomarker of tubular injury, and 
decreased uCathL levels, are found in children with 
DM1 without GH. These changes also precede the in-
crease of ACR, hence, tubular injury seems to be earlier 
than the glomerular changes. On the other hand, in 
the early stage of kidney dysfunction in diabetes, we 
cannot exclude the impact of glomerular hyperfiltra-
tion on NGAL and Cath urinary loss as a positive 
correlation between uNGAL and eGFR was found in 
our study. This was suggested previously in an ani-
mal model of diabetic nephropathy [22]. Moreover, in 
patients with DM2, correlations between sNGAL, uN-
GAL and residual GFR were also found. These patients 
showed also a positive correlation between sNGAL 
and uNGAL [23]. In the present study, a positive cor-
relation between sNGAL and uNGAL was found only 
in patients without GH. These children showed a cor-
relation between sNGAL and WBC, which represents 
an important physiological source of this protein. This 
might suggest that the significant increase of uNGAL 
in this subgroup may result only from tubular injury. 
Interestingly, in patients with glomerular hyperfil-
tration, an inverse correlation between uNGAL and 
sNGAL was found, which may indicate an enhanced 
impact of GH on serum and urinary levels of studied 
biomarkers. The effect of hyperfiltration has also been 
expressed in uCathL, which showed a positive cor-
relation with eGFR. 
Taken together, these observations support the pri-
mary ‘tubular hypothesis’ of diabetic kidney disease. 
The results of our study showed increased albuminuria 
in patients with GH and in patients with poor glycae-
mic control compared to controls. Hence, albuminuria 
may be considered related to increased glomerular 
filtration and may reflect diabetic glomerular damage 
[29]. However, no correlation between ACR and eGFR 
was revealed. 
Table V. Statistical correlations between studied parameters in the diabetic group
Tabela V. Ocena zależności pomiędzy badanymi parametrami u dzieci z cukrzycą
Parameters ACR [mg/g]   eGFR [mL/min/1.73 m2] HbA1c (%) WBC(*10
3/mm3)
sNGAL [ng/mL] NS NS NS  r = 0.275
 p = 0.030
uNGAL [ng/mg] r = 0.365
p = 0.004
r = 0.331
p = 0.045
r = 0.287
p = 0.028
NS
uCathL [ng/mg] NS r = 0.501
p = 0.034
NS NS
NA — not applicable; NS — not significant; r — correlation coefficient; p — confidence level
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The analysis of the relationship between glycaemic 
control and the analysed biomarkers revealed a posi-
tive correlation between HbA1c and uNGAL, contrary 
to the reports of other authors [11, 23]. Significantly 
elevated ACR and eGFR values were only found in 
patients with poor glycaemic control; these results 
underpin the usefulness of NGAL and uCathL as early 
biomarkers of DKD.
This study has some limitations. Firstly, the study 
group is relatively small. Secondly, we did not evalu-
ate the time-dependent changes of NGAL and uCathL 
levels. Thirdly, this was only one cross-sectional study 
and further studies on humans are needed to elucidate 
these points.
Conclusions
This study shows that some abnormalities suggesting 
early and subclinical kidney injury can be traced in 
children with DM1 and ‘normal’ renal function. Low-
range albuminuria and normal eGFR do not exclude 
early kidney injury if defined as changes of sNGAL, uN-
GAL and uCathL concentrations. These changes may 
occur even in children without GH and with optimal 
glycaemic control. Glomerular hyperfiltration appears 
to enhance the observed changes. The earliest signs of 
kidney dysfunction manifested by changes of uNGAL 
and uCathL seem to result from tubular damage. Our 
study highlights the value of NGAL and uCathL as 
potential predictors for early DKD detection. 
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